Zimmer Biomet Holdings Inc (ZBH)
Debt-to-capital ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 4,867,900 | 5,152,200 | 5,463,700 | 7,626,500 | 6,721,400 |
Total stockholders’ equity | US$ in thousands | 12,480,500 | 12,020,300 | 12,660,700 | 12,194,200 | 12,388,100 |
Debt-to-capital ratio | 0.28 | 0.30 | 0.30 | 0.38 | 0.35 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $4,867,900K ÷ ($4,867,900K + $12,480,500K)
= 0.28
The debt-to-capital ratio of Zimmer Biomet Holdings Inc has shown a decreasing trend from 0.40 in 2019 and 2020 to 0.36 in 2021 and remained constant at 0.32 in both 2022 and 2023. This ratio indicates that the company relies on debt for approximately 32% to 40% of its capital structure over the past five years. A lower debt-to-capital ratio generally signifies a lower level of financial risk and a stronger equity base. Zimmer Biomet's consistent ratio in recent years suggests a stable leverage position, which may be viewed positively by investors and creditors. However, it is essential to monitor this ratio over time to assess any potential shifts in the company's capital structure and debt management practices.
Peer comparison
Dec 31, 2023